Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study.

BMC Infect Dis · 2013 · PMC3680019 · PMID 23734829

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

This study however demonstrates that even with similar efavirenz plasma concentrations in both treatment groups, neuropsychiatric symptoms did not differ implying that anti-TB treatment related neuropsychiatric effects may not be significant among Ugandan HIV patients treated with efavirenz based regimens.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.